Related Experiment Video
Updated: Jun 24, 2026
Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
Models of ovarian cancer metastasis: Murine models
1Massachusetts General Hospital, Harvard Medical School, 13th Street, Building 149, CNY7, Charlestown, MA 02129, United States.
Abstract:
Mice have mainly been used in ovarian cancer research as immunodeficient hosts for cell lines derived from the primary tumors and ascites of ovarian cancer patients. These xenograft models have provided a valuable system for pre-clinical trials, however, the genetic complexity of human tumors has precluded the understanding of key events that drive metastatic dissemination. Recently developed immunocompetent, genetically defined mouse models of epithelial ovarian cancer represent significant improvements in the modeling of metastatic disease.
Insights
Immunocompetent mouse models improve ovarian cancer research by better mimicking human tumor metastasis. These genetically defined models offer advancements over traditional xenografts for studying metastatic disease progression.
Area of Science:
- * Ovarian cancer research and preclinical modeling.
Background:
- * Mice are commonly used as immunodeficient hosts for human ovarian cancer cell lines (xenografts).
- * Traditional xenograft models have limitations in capturing the genetic complexity of human tumors, hindering the study of metastatic dissemination.
- * Understanding metastatic events is crucial for developing effective ovarian cancer treatments.
Purpose of the Study:
- * To highlight the advancements in mouse models for epithelial ovarian cancer research.
- * To introduce immunocompetent, genetically defined mouse models as superior alternatives for studying metastatic disease.
Main Methods:
- * Review and comparison of traditional xenograft models versus novel immunocompetent mouse models.
- * Focus on genetically defined models that better represent human ovarian cancer.
Main Results:
- * Novel mouse models offer significant improvements in modeling epithelial ovarian cancer.
- * These models more accurately reflect the genetic complexity and metastatic potential of human tumors.
- * Advancements facilitate a deeper understanding of key events driving metastatic dissemination.
Conclusions:
- * Immunocompetent, genetically defined mouse models represent a significant leap forward in ovarian cancer research.
- * These improved models are essential for accurately studying and ultimately combating ovarian cancer metastasis.
